M14-002 - ABT-450/r/ABT-267 & ABT-333 with and without RBV

• Research type

  Research Study

• Full title

  A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in Treatment-Naïve Adults with Genotype 1a Chronic Hepatitis C Virus (HCV) Infection (PEARL-IV)

• IRAS ID

  124243

• Contact name

  Ashley Brown

• Contact email

  Ashley.Brown@imperial.nhs.uk

• Sponsor organisation

  Abbvie Ltd

• Eudract number

  2012-005522-29

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  London - City & East Research Ethics Committee

• REC reference

  13/LO/0425

• Date of REC Opinion

  17 Apr 2013

• REC opinion

  Further Information Favourable Opinion